Serum from hepatocellular carcinoma patients
1 paper3 findings
- 1 lab in 1 country
- Funders: Science and Technology Development Fund and 1 more
- Cells1
Outcomes
3Apoptosis
downin human cells1
1 study
Apoptosis
downin human cells1
Serum from hepatocellular carcinoma patients decrease apoptosis in human cells.
“decreased percentage of early and late apoptotic cells.”
Cellsin Huh-7 cells
HeliyonFeb 1, 2024
Cellular proliferation
upin human cells1
1 study
Cellular proliferation
upin human cells1
Serum from hepatocellular carcinoma patients increase cellular proliferation in human cells.
“HCC serum-treated Huh-7 cancer cells on the other hand displayed higher tumor aggressiveness as depicted by altered morphology, increased cellular proliferation and migration”
Cellsin Huh-7 cells
HeliyonFeb 1, 2024
Cellular senescence
upin human cells1
1 study
Cellular senescence
upin human cells1
Serum from hepatocellular carcinoma patients induce cellular senescence in human cells.
“HCC serum-treated hA-MSCs suffered oncogene-induced senescence as shown by their altered morphology and ameliorated proliferation and differentiation.”
Cellsin hA-MSCs
HeliyonFeb 1, 2024
Latest
Heliyon
Hepatocellular carcinoma patients serum modulates the regenerative capacities of adipose mesenchymal stromal cells
Experiments in human cellsMechanisms